410 related articles for article (PubMed ID: 28109957)
1. Adoptive Transfer of mRNA-Transfected T Cells Redirected against Diabetogenic CD8 T Cells Can Prevent Diabetes.
Fishman S; Lewis MD; Siew LK; De Leenheer E; Kakabadse D; Davies J; Ziv D; Margalit A; Karin N; Gross G; Wong FS
Mol Ther; 2017 Feb; 25(2):456-464. PubMed ID: 28109957
[TBL] [Abstract][Full Text] [Related]
2. Immunotargeting of insulin reactive CD8 T cells to prevent diabetes.
Scott GS; Fishman S; Khai Siew L; Margalit A; Chapman S; Chervonsky AV; Wen L; Gross G; Wong FS
J Autoimmun; 2010 Dec; 35(4):390-7. PubMed ID: 20850948
[TBL] [Abstract][Full Text] [Related]
3. Selective immunotargeting of diabetogenic CD4 T cells by genetically redirected T cells.
Perez S; Fishman S; Bordowitz A; Margalit A; Wong FS; Gross G
Immunology; 2014 Dec; 143(4):609-17. PubMed ID: 24943731
[TBL] [Abstract][Full Text] [Related]
4. RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null nonobese diabetic mice.
Kay TW; Parker JL; Stephens LA; Thomas HE; Allison J
J Immunol; 1996 Oct; 157(8):3688-93. PubMed ID: 8871671
[TBL] [Abstract][Full Text] [Related]
5. Genetic and therapeutic control of diabetogenic CD8+ T cells.
Santamaria P
Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463
[TBL] [Abstract][Full Text] [Related]
6. Xenogeneic beta 2-microglobulin substitution affects functional binding of MHC class I molecules by CD8+ T cells.
Benoit LA; Tan R
J Immunol; 2007 Sep; 179(6):3588-95. PubMed ID: 17785793
[TBL] [Abstract][Full Text] [Related]
7. Requirement for both H-2Db and H-2Kd for the induction of diabetes by the promiscuous CD8+ T cell clonotype AI4.
Takaki T; Lieberman SM; Holl TM; Han B; Santamaria P; Serreze DV; DiLorenzo TP
J Immunol; 2004 Aug; 173(4):2530-41. PubMed ID: 15294969
[TBL] [Abstract][Full Text] [Related]
8. Prevalent CD8(+) T cell response against one peptide/MHC complex in autoimmune diabetes.
Anderson B; Park BJ; Verdaguer J; Amrani A; Santamaria P
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9311-6. PubMed ID: 10430939
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Survey of miRNA-mRNA Interactions Reveals That Ccr7 and Cd247 (CD3 zeta) are Posttranscriptionally Controlled in Pancreas Infiltrating T Lymphocytes of Non-Obese Diabetic (NOD) Mice.
Fornari TA; Donate PB; Assis AF; Macedo C; Sakamoto-Hojo ET; Donadi EA; Passos GA
PLoS One; 2015; 10(11):e0142688. PubMed ID: 26606254
[TBL] [Abstract][Full Text] [Related]
10. Chimeric beta2 microglobulin/CD3zeta polypeptides expressed in T cells convert MHC class I peptide ligands into T cell activation receptors: a potential tool for specific targeting of pathogenic CD8(+) T cells.
Margalit A; Fishman S; Berko D; Engberg J; Gross G
Int Immunol; 2003 Nov; 15(11):1379-87. PubMed ID: 14565936
[TBL] [Abstract][Full Text] [Related]
11. Prevention of "Humanized" diabetogenic CD8 T-cell responses in HLA-transgenic NOD mice by a multipeptide coupled-cell approach.
Niens M; Grier AE; Marron M; Kay TW; Greiner DL; Serreze DV
Diabetes; 2011 Apr; 60(4):1229-36. PubMed ID: 21346176
[TBL] [Abstract][Full Text] [Related]
12. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent.
Serreze DV; Chapman HD; Varnum DS; Gerling I; Leiter EH; Shultz LD
J Immunol; 1997 Apr; 158(8):3978-86. PubMed ID: 9103469
[TBL] [Abstract][Full Text] [Related]
13. APC-targeted proinsulin expression inactivates insulin-specific memory CD8
Reeves PL; Rudraraju R; Liu X; Wong FS; Hamilton-Williams EE; Steptoe RJ
Immunol Cell Biol; 2017 Oct; 95(9):765-774. PubMed ID: 28611473
[TBL] [Abstract][Full Text] [Related]
14. Beta cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice.
de Jersey J; Snelgrove SL; Palmer SE; Teteris SA; Mullbacher A; Miller JF; Slattery RM
Proc Natl Acad Sci U S A; 2007 Jan; 104(4):1295-300. PubMed ID: 17229843
[TBL] [Abstract][Full Text] [Related]
15. MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice.
Serreze DV; Holl TM; Marron MP; Graser RT; Johnson EA; Choisy-Rossi C; Slattery RM; Lieberman SM; DiLorenzo TP
J Immunol; 2004 Jan; 172(2):871-9. PubMed ID: 14707058
[TBL] [Abstract][Full Text] [Related]
16. Developing a novel model system to target insulin-reactive CD8 T cells.
Scott GS; Fishman S; Margalit A; Siew LK; Chapman S; Wen L; Gross G; Wong FS
Ann N Y Acad Sci; 2008 Dec; 1150():54-8. PubMed ID: 19120267
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of the innate immune adaptor STING promotes autoreactive T cell expansion in NOD mice.
Akazawa S; Mackin L; Jhala G; Fynch S; Catterall T; Selck C; Graham KL; Krishnamurthy B; Pappas EG; Kwong CJ; Sutherland APR; Kay TWH; Brodnicki TC; Thomas HE
Diabetologia; 2021 Apr; 64(4):878-889. PubMed ID: 33483762
[TBL] [Abstract][Full Text] [Related]
18. An altered CD8
Zhang M; Wang S; Guo B; Meng G; Shu C; Mai W; Zheng Q; Chen X; Wu Y; Wang L
Cell Mol Immunol; 2019 Jun; 16(6):590-601. PubMed ID: 29955175
[TBL] [Abstract][Full Text] [Related]
19. A TCR-like antibody against a proinsulin-containing fusion peptide ameliorates type 1 diabetes in NOD mice.
Matsumoto Y; Kishida K; Matsumoto M; Matsuoka S; Kohyama M; Suenaga T; Arase H
Biochem Biophys Res Commun; 2021 Jan; 534():680-686. PubMed ID: 33208230
[TBL] [Abstract][Full Text] [Related]
20. Chimeric antigen receptor (CAR) T cells targeting a pathogenic MHC class II:peptide complex modulate the progression of autoimmune diabetes.
Zhang L; Sosinowski T; Cox AR; Cepeda JR; Sekhar NS; Hartig SM; Miao D; Yu L; Pietropaolo M; Davidson HW
J Autoimmun; 2019 Jan; 96():50-58. PubMed ID: 30122420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
